Risk stratification and medical therapy of pulmonary arterial hypertension
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Pulmonary arterial hypertension (PAH) remains a severe clinical condition despite the availability over the past 15 years of multiple drugs interfering with the endothelin, nitric oxide and prostacyclin pathways. The recent progress observed in medical therapy of PAH is not, therefore, related to the discovery of new pathways, but to the development of new strategies for combination therapy and on escalation of treatments based on systematic assessment of clinical response. The current treatment strategy is based on the severity of the newly diagnosed PAH patient as assessed by a multiparametric risk stratification approach. Clinical, exercise, right ventricular function and haemodynamic parameters are combined to define a low-, intermediate- or high-risk status according to the expected 1-year mortality. The current treatment algorithm provides the most appropriate initial strategy, including monotherapy, or double or triple combination therapy. Further treatment escalation is required in case low-risk status is not achieved in planned follow-up assessments. Lung transplantation may be required in most advanced cases on maximal medical therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 Time-course of completed randomised controlled trials (RCTs) in pulmonary arterial hypertension (PAH) (n=41) according to treatment strategy. SSc: systemic sclerosis; IPAH: idiopathic PAH. Reproduced and modified from [70] with permission.](https://figures.cochat.ai/paper-figures/44281cb9913845f29b53a42c8e3258e5/risk-stratification-and-medical-therapy-of-pulmonary-arterial-hypertension-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other high-risk profiles include familial PAH, PVOD, CTD-PAH, CTD-PAH associated with concomitant ILD, rapidly progressive disease despite therapy, and development of hemoptysis.(282, 291–293)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In particular, the 2018 World Symposium on Pulmonary Hypertension strongly recommends serial parametric risk assessment.(282)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
The cited source says what the claim attributes to it.
In the citing paper
“The 2018 World Symposium on Pulmonary Hypertension states that the ultimate goal of therapy for patients with PAH is to achieve a low-risk status, assessed either by REVEAL or the ESC/ERS model.(282)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationHaemodynamic definitions and updated clinical classification of pulmonary hypertension
Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01913-2018 · Cited by 3,813
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationBosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Self-citationBarst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,698
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Self-citationInhaled Iloprost for Severe Pulmonary Hypertension
Olschewski, H., Simonneau, G., Galiè, N., Higenbottam, T., Naeije, R., Rubin, L. J., Nikkho, S., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,783
Self-citationBenza, R. L., Miller, D. P., Gomberg-Maitland, M., Frantz, R. P., Foreman, A. J., Coffey, C. S., Frost, A., Barst, R. J., Badesch, D. B., Elliott, C. G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.898122 · Cited by 1,547
Self-citationChannick, R. N., Simonneau, G., Sitbon, O., Robbins, I. M., Frost, A., Tapson, V. F., Badesch, D. B., Roux, S., Rainisio, M., Bodin, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06250-x · Cited by 1,534
Self-citation
Research works printed but not linked: 2
- Benza, 2018, Comparison of three assessment strategies as predictors of one-year survival in US pulmonary arterial hypertension (PAH) patients, Am J Respir Crit Care Med, 197, A7649
- Galiè, 2014, AMBITION: a randomised, multicenter study of first-line ambrisentan and tadalafil combination therapy in subjects with pulmonary arterial hypertension (PAH), Eur Respir J, 44, 2916
Cited by
Items 801–897 of 897
Abbas, M. T., Farina, J., Mahmoud, A., Wraith, R. E., Brown, L. S., Baxter, C. M., Mohammed, A., Sheashaa, H., Ibrahim, O., Awad, K., et al. (2025) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-025-03506-7
Rehabilitation applications and progress in managing pulmonary hypertension
Liu, Y., Guo, X., Liu, P., Jia, S., Wang, F., Li, F., Yuan, P., & Wang, X. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1659818
Pulmonary hypertension: diagnostic method to test the true curative efficacy of a drugPreprint
Vanni, R. (2025) · Research Square · doi:10.21203/rs.3.rs-7706035/v1
Minatsuki, S., Hatano, M., Ishii, S., Hirose, K., Matsuoka, R., Kiriyama, H., Saito, A., Yagi, H., Ishida, J., Komuro, I., et al. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.134009
Primary Pulmonary Hypertension
Arvanitaki, A., & Giannakoulas, G. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-702-08231-3.00067-3
Genecand, L. (2023) · Archive ouverte UNIGE (University of Geneva) · doi:10.13097/archive-ouverte/unige:170488
Additional file 1 of Risk assessment in precapillary pulmonary hypertension: a comparative analysis
Sonnweber, T., Schneider, E.-M., Nairz, M., Theurl, I., Weiss, G., Tymoszuk, P., & Löffler‐Ragg, J. (2021) · Figshare · doi:10.6084/m9.figshare.13627213
Yuan, Y., Li, S., Yan, M., Yang, Y., Zhong, C., & Hu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26720445
Sonnweber, T., Tymoszuk, P., Steringer‐Mascherbauer, R., Sigmund, E., Porod-Schneiderbauer, S., Kohlbacher, L., Theurl, I., Lang, I., Weiss, G., & Löffler‐Ragg, J. (2024) · Figshare · doi:10.6084/m9.figshare.26584863
Davis, S., Edwards, T., Norcross, L., Fehnel, S. E., Beaudet, A., Eckart, M., & Fastenau, J. M. (2024) · Figshare · doi:10.6084/m9.figshare.26655397
Benjamin, N. (2023) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00032713
Gluschke, H. (2024) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-43413
Gong, C., Guo, J., Wan, K., Wang, L., Chen, X., Guo, J., He, J., Yin, L., Wen, B., Pu, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21593928
Weiss, T., Rosen Ramey, D., Yang, L., Liu, X., Patel, M. J., Rajpathak, S. N., Bajwa, E. K., & Lautsch, D. (2022) · Figshare · doi:10.6084/m9.figshare.21358101
Gong, C., Guo, J., Wan, K., Wang, L., Chen, X., Guo, J., He, J., Yin, L., Wen, B., Pu, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21593931
Yuan, Y., Li, S., Yan, M., Yang, Y., Zhong, C., & Hu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26720448
Imai, S., Sakao, S., Nagata, J., Naito, A., Sekine, A., Sugiura, T., Shigeta, A., Nishiyama, A., Yokota, H., Shimizu, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25303036
Elspaß, S. I. (2023) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-32286
Risk assessment in pulmonary hypertension
Stubbs, H. D. (2024) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.84813
Davis, S., Edwards, T., Norcross, L., Fehnel, S. E., Beaudet, A., Eckart, M., & Fastenau, J. M. (2024) · Figshare · doi:10.6084/m9.figshare.26655394
Davis, S., Edwards, T., Norcross, L., Fehnel, S. E., Beaudet, A., Eckart, M., & Fastenau, J. M. (2024) · Figshare · doi:10.6084/m9.figshare.26655391
Oliver-Hernandez, G., & Medina, L. D. (2021) · Repositorio Institucional E-DocUR (Universidad Del Rosario) · doi:10.48713/10336_32223
Xanthouli, P., Theobald, V., Benjamin, N., Marra, A. M., D’Agostino, A., Egenlauf, B., Shaukat, M., Ding, C., Cittadini, A., Bossone, E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16969285
Self-citationPalevičiūtė, E., Čelutkienė, J., Šimbelytė, T., Gumbienė, L., Jurevičienė, E., Zakarkaitė, D., Čėsna, S., Eichstaedt, C. A., Benjamin, N., & Grünig, E. (2024) · Figshare · doi:10.6084/m9.figshare.26583369
Self-citationDavis, S., Edwards, T., Norcross, L., Fehnel, S. E., Beaudet, A., Eckart, M., & Fastenau, J. M. (2024) · Figshare · doi:10.6084/m9.figshare.26655400
Richter, M. J., & Justus Liebig University Giessen (2019) · University writing server of the Justus Liebig University Giessen (Justus-Liebig-Universität Gießen) · doi:10.22029/jlupub-14994
Kirchberg, C. (2024) · Common Library Network (Der Gemeinsame Bibliotheksverbund) · doi:10.22032/dbt.62578
Imai, S., Sakao, S., Nagata, J., Naito, A., Sekine, A., Sugiura, T., Shigeta, A., Nishiyama, A., Yokota, H., Shimizu, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25303169
Yuan, Y., Li, S., Yan, M., Yang, Y., Zhong, C., & Hu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26720442
Swaminathan, A. C., Zhu, H., Tapson, V., Lokhnygina, Y. V., Poms, A. D., Kelleher, Z., Gaspard, E., Kennedy, K., Fee, B. E., Fortin, T., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13265820
Nagata, J., Sekine, A., Tanabe, N., Taniguchi, Y., Ishida, K., Shiko, Y., Sakao, S., Tatsumi, K., & Suzuki, T. (2022) · Figshare · doi:10.6084/m9.figshare.20346969
Schuler, K., Hemnes, A. R., Annis, J., Farber‐Eger, E. H., Lowery, B. D., Halliday, S. J., & Brittain, E. L. (2022) · Figshare · doi:10.6084/m9.figshare.19923253
Imai, S., Sakao, S., Nagata, J., Naito, A., Sekine, A., Sugiura, T., Shigeta, A., Nishiyama, A., Yokota, H., Shimizu, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26686047
Tielemans, B. (2020) · Lirias (KU Leuven)
Redin Palacios, O. (2023) · Communities in ADDI (University of the Basque Country)
Toepassingen van Machinaal Leren in de Pneumologie: Hulpmiddelen voor Klinische Besluitvorming
Verstraete, K. (2024) · Lirias
Cé, L. C. (2023) · Lume (Universidade Federal do Rio Grande do Sul)
Costa, G. O. S. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Nattmann, P. (2023) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Improving the Diagnosis and Assessment of Pulmonary Hypertension by Optimising Clinical Pathways
Durrington, C. (2023) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
ORLANDO, F. (2025) · Electronic Theses and Dissertations Repository (University of Pisa)
Dignam, J. P. (2023) · Queen Mary Research Online (Queen Mary University of London)
Torralba García, Y. (2020) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Fiedler, D. (2023) · Common Library Network (Der Gemeinsame Bibliotheksverbund)
Ahmed, A. (2025) · Lund University Publications (Lund University)
Machado, R. S. (2025) · Lume (Universidade Federal do Rio Grande do Sul)
Zhang, Y., Zhang, Y., Yang, S., Huang, Y., Zhang, Y., Ye, Z., Xiang, H., Gan, X., Hou, F. F., & Qin, X. (2025) · MedScience · doi:10.1007/s11684-025-1183-x
Wei, Q., Zhang, Y., Dai, J., Shan, L., Gong, H., Zhang, Y., Tang, Y., Li, D., Li, L., Sun, X., et al. (2025) · Clinical Rheumatology · doi:10.1007/s10067-025-07879-x
Gerson, R. B. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Pulmonary hypertension: diagnostic method to test the true curative efficacy of a drugPreprint
Vanni, R. (2026) · Research Square · doi:10.21203/rs.3.rs-7706035/v2
Onkolojik Tedaviye Bağlı Pulmoner Hipertansiyonda Tanı ve Tedavi Yaklaşımları
Zencirci, A. E. (2021) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.42.c4248
Pulmonary hypertension: diagnostic method to test the true curative efficacy of a drugPreprint
Vanni, R. (2026) · Research Square · doi:10.21203/rs.3.rs-7706035/v3
Dardi, F., McCullagh, B. N., Ferreira, F. M. A., Meandzija, M., Stulnig, G., Neill, W., & Cruz‐Utrilla, A. (2026) · ERJ Open Research · doi:10.1183/23120541.01693-2025
Alowami, M., Ch’ng, B. X., Babasola, R. O., Tan, C. H., Koh, M. H., Harvard, A., West, B., Sohail, S., Rahmaan, A., Sutanto, J., et al. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001185
Epidemiology and Diagnosis of Pulmonary Arterial Hypertension
Kearney, K. L. (2025) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/32050
Padervinskienė, L. (2020) · Lithuanian University of Health Sciences
Evaluation of Frailty and Skeletal Muscle Function in Patients with Pulmonary Hypertension
Momen, R. (2024) · TSpace (University of Toronto)
Muñoz, A. R. L. (2023) · Repositorio CES
Maele, A. V. D., Belge, C., Delcroix, M., Willaert, X., Rex, S., & Sloovere, V. D. (2025) · Acta Anaesthesiologica Belgica · doi:10.56126/76.s.17
Nagata, J. (2023) · Institutional Repositories DataBase (IRDB) · doi:10.20776/900122167
Verrès, Y. (2021) · theses.fr (ABES) · doi:10.70675/1329dc6fz8c40z4025za800z88f8204abb40
Design of a pacemaker for animal biomedical research on pulmonary arterial hypertension
Pan, F. (2024) · theses.fr (ABES) · doi:10.70675/cf854ae1z5ec3z41fbza5d4z827820da0f02
Exercise testing for evaluating right ventricular (RV) function in pulmonary hypertension – A review
Farooq, T., Mohsin, M., Fatima, W., Ali, D., Nusrat, A., Sajid, B., Ahsan, M., Janoowala, T., Amir, A., & Mansoor, V. (2026) · Lung India · doi:10.4103/lungindia.lungindia_641_25
Calabrò, G. E., de Belvis, A. G., Bert, F., Moro, G. L., Scaioli, G., D’Ambrosio, F., Donno, R. D., Scarfagna, C., Ricciardi, R., Vizza, D., et al. (2026) · Journal of preventive medicine and hygiene · doi:10.82082/2421-4248/jpmh2026.67.1s1
Camacho, R. E. C., Tuta-Quintero, E., González-García, M., Rubiano, W., Rincón-Álvarez, E., Díaz, K., & Giraldo‐Cadavid, L. F. (2026) · Pulmonary Medicine · doi:10.1155/pm/2867844
Camacho, R. E. C., Orozco‐Levi, M., Tuta-Quintero, E., Gómez-Paláu, R., Londoño, A., & Giraldo‐Cadavid, L. F. (2026) · Revista Colombiana de Cardiología · doi:10.24875/rccar.25000044
Kramer, M. R., Bartolome, S., Saggar, R., Bourge, R. C., Ford, H. J., Medarov, B. I., Sager, J. S., Shapiro, S., Waxman, A. B., Ishizawar, D. C., et al. (2026) · BMC Pulmonary Medicine · doi:10.21203/rs.3.rs-9556444/v1
Evolution of Exercise Training in Patients with Pulmonary Hypertension—A Comprehensive Review
Beis, I., Δίπλα, Κ., Boutou, A., Zacharias, A., Pataka, A., Sourla, E., Zafeiridis, A., & Pitsiou, G. (2026) · Healthcare · doi:10.3390/healthcare14121796
Camacho, R. E. C., Orozco‐Levi, M., Tuta-Quintero, E., Gómez-Paláu, R., Londoño, A., & Giraldo‐Cadavid, L. F. (2026) · Revista Colombiana de Cardiología (English Edition) · doi:10.24875/rccare.m26000216
Mixed Pulmonary Hypertension: HIV Infection as an Underlying Cause
Donado-Botero, R., Tibocha-Gordón, I., Montoya-Jaramillo, M., Mesa-Beltrán, I., Mendoza-Leottau, K., Ibañez-Sanchez, K., Benitez-Escobar, M. C., Jimenez-Petro, A., Macias-Posada, E., Salaiman-Serpa, M. R., et al. (2025) · Trends in Internal Medicine · doi:10.33425/2771-5906.1042
Three-Dimensional Cardiac Tissue Models for Pharmaceutical Research
Lu, X., Xie, B., Zhong, J., Xie, R., & Peng, W. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.6c00217
Pulmoner Hipertansiyon: Tanıdan İleri Tedaviye Multidisipliner Yaklaşım
Pazarlı, A. C., Afşar, G. Ç., Tanülkü, U., Arınç, S., Şıvgın, H., Yurttaş, A., Çelik, D., Çeker, M. E., Karaman, K., Yazıcı, D. T., et al. (2026) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.4300
Ahmed, M., Zal, A., Zahiri, Z., Meshkati, H., Ashraf, H., Hassan, E. M. A. N., Jain, H., Ahmed, F., Chigurupati, H. D., & Neppala, S. (2026) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000002194
Thompson, E. J., Li, J. S., & Hornik, C. P. V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11851-7.00026-4
Chiaki, G. (2022) · Institutional Repositories DataBase (IRDB)
Faeq, A., Habeeb, M. A., & Faeq, K. (2026) · Advanced medical journal · doi:10.56056/amj.2026.515
Huang, T.-H., Lin, Y.-S., Hsu, C.-Y., Huang, D.-S., Chung, S., & Morgan, F. (2026) · PubMed · doi:10.6515/acs.202609_42(5).20260112d
pKa Estimation of Ambrisentan by Reversed-Phase High-Performance Liquid Chromatography
Tütüncü, E., & Dereli, D. B. (2026) · Bitlis Eren Üniversitesi Fen Bilimleri Dergisi · doi:10.17798/bitlisfen.1917355
o'g'li, H. M. A. A. D. T. (2026) · IQRO
Ghaffary, S. G. M. R. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.04.261
Chen, L., Zhang, Z., Lan, X., Chen, W., 方秋月, Huang, H., Chen, S., & Wang, Y. (2026) · Pulmonary Circulation · doi:10.1002/pul2.70404
Ravichandran, A. K., Beaudet, A., López, D., Lew, C. R., Varker, H., Jerry, M., & Muralidhar, A. (2026) · Pulmonary Circulation · doi:10.1002/pul2.70414
Real World, Very-Long Term Survival of Incident Patients with Pulmonary Hypertention
Festas, T. C. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Pulmonary hypertension: modern approaches to diagnosis and treatment
Shust, O. G., Pisaryk, D. M., Anisova, N. S., Bovtiuk, N. Y., & Apanasovich, V. H. (2026) · Military Medicine · doi:10.51922/2074-5044.2026.4.110
The Role of Mitochondrial Hyperacetylation and Sirtuin Activity in Pulmonary Arterial Hypertension
Ramírez, J. B. (2021) · Repositorio del Tecnológico de Monterrey (Tecnológico de Monterrey)
Ma, R., Cheng, L., Song, Y., Sun, Y., Gui, W., Deng, Y., Xie, C., & Liu, M. (2022) · doi:10.3389/fmed.2022.940784.s002
Shang, Z., Sun, J., Hui, J., Yu, Y., Bian, X., Yang, B., Deng, K., & Lin, L. (2021) · doi:10.3389/fgene.2021.781011.s004
Richter, M. J., Zedler, D., Berliner, D., Douschan, P., Gall, H., Ghofrani, H. A., Kimmig, L., Kremer, N., Olsson, K. M., da Rocha, B. B., et al. (2021) · doi:10.3389/fcvm.2021.775039.s001
Lokhorst, C., van der Werf, S., Berger, R. M. F., & Douwes, J. M. (2022) · doi:10.3389/fcvm.2022.1035453.s001
Zhang, Z., Liu, C., Bai, Y., Li, X., Gao, X., Li, C., Guo, G., Chen, S., Sun, M., Liu, K., et al. (2022) · doi:10.3389/fphar.2022.920222.s001
Lai, J., Zhao, J., Li, K., Qin, X., Wang, H., Tian, Z., Wang, Q., Li, M., Guo, X., Liu, Y., et al. (2022) · doi:10.3389/fcvm.2022.872795.s001
Lago-Docampo, M., Solarat, C., Méndez-Martínez, L., Baloira, A., & Valverde, D. (2022) · doi:10.3389/fcvm.2022.823133.s001
Li, J., Yang, Z.-Y., Wang, S., Yuan, P., Zhao, Q.-H., Gong, S.-G., Qiu, H.-L., Luo, C.-J., Li, H.-T., Zhang, R., et al. (2022) · doi:10.3389/fcvm.2022.977110.s002
Rubio, M. C., Esmaili, S., Olmos, C., de Agustín, J. A., Esmaili, I., Cardenas, F. O., Sampedro, C. S., Martín-Caro, L. G., Rodríguez, A., Cogolludo, A. L., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15229039
Metadata
- Authors
- Galiè, N., Channick, R. N., Frantz, R. P., Grünig, E., Jing, Z. C., Moiseeva, O., Preston, I. R., Pulido, T., Safdar, Z., Tamura, Y., & McLaughlin, V. V.
- Affiliations
- University of Bologna (IT)
- Harvard University (US)
- Mayo Clinic (US)
- University Hospital Heidelberg (DE)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Tufts University (US)
- Houston Methodist (US)
- International University of Health and Welfare (JP)
- University of Michigan (US)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801889
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351343
- OpenAlex
- W2904385559
- Cited by
- 819
- References
- 88
- Citations by year
- 2026: 32 · 2025: 46 · 2024: 101 · 2023: 108 · 2022: 174 · 2021: 169 · 2020: 128 · 2019: 58
- FWCI
- 15.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
- Funders
- Japan Society for the Promotion of Science (18K08183)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- pulmonary arterial hypertension, risk stratification, medical therapy, combination therapy, treatment escalation, endothelin receptor antagonists, phosphodiesterase-5 inhibitors, prostacyclin analogues, right ventricular function, exercise capacity, one-year mortality, lung transplantation, treatment algorithm
- MeSH terms
- Pulmonary Arterial Hypertension, Calcium Channel Blockers, Humans, Randomized Controlled Trials as Topic, Lung Transplantation, Practice Guidelines as Topic, Risk Assessment, Phosphodiesterase 5 Inhibitors, Endothelin Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.